Evidence map›Paper›PMID 21756512›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2011

Tuberculosis in HIV programmes in lower-income countries: practices and risk factors.

L Fenner, M Forster, A Boulle, S Phiri, P Braitstein, C Lewden, M Schechter, N Kumarasamy, M Pascoe, E Sprinz and 11 more

Open access · greenAbstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Tuberculosis screening outcomes for newly diagnosed persons living with HIV, Nyanza Province, Kenya, 2009.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2016
    Article
  10. Article
  11. Article
  12. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 10 countries.

L FennerInstitute of Social and Preventive Medicine, Berne, Switzerland. lfenner@ispm.unibe.ch
M Forster
A Boulle
S Phiri
P Braitstein
C Lewden
M Schechter
N Kumarasamy
M Pascoe
E Sprinz
D R Bangsberg
P S Sow
D Dickinson
M P Fox
J McIntyre
M Khongphatthanayothin
F Dabis
M W G Brinkhof
R Wood
M Egger
ART-LINC of IeDEA
University of Bern · CHUniversité de Bordeaux · FREES Research (United Kingdom) · GBLighthouse Trust · MWMoi University · KEPerinatal HIV Research Unit · ZAThai Red Cross Society · THUniversidade Federal do Rio de Janeiro · BRUniversidade Federal do Rio Grande do Sul · BRUniversity of Madras · INUniversity of the Witwatersrand · ZA

Funding

Observational Antiretroviral Studies In Southern Africa (OASIS) CollaborationU01AI069924 · NIAID · UNIVERSITAT BERN · PI Cleophas Chimbetete, Mary-Ann Davies · 2006 to 2026
$55.9M
WADA (West Africa Database on Antiretroviral Therapy) CollaborationU01AI069919 · NIAID · UNIVERSITY OF BORDEAUX II · PI Didier Koumavi Ekouevi, Antoine Jaquet · 2006 to 2026
$29.9M
Rates, Predictors and Mortality Impact of Losses from HIV Care in South AfricaK01AI083097 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FOX, MATTHEW ALEXANDER PEASE · 2009 to 2013
$615k
NIAID NIH HHS K01 AI083097NIAID NIH HHS U01 AI069919NIAID NIH HHS U01 AI069924
6 · The paper itself

Abstract

backgroundTuberculosis (TB) is a common diagnosis in human immunodeficiency virus (HIV) infected patients on antiretroviral treatment (ART).

objectiveTo describe TB-related practices in ART programmes in lower-income countries and identify risk factors for TB in the first year of ART.

methodsProgramme characteristics were assessed using standardised electronic questionnaire. Patient data from 2003 to 2008 were analysed and incidence rate ratios (IRRs) calculated using Poisson regression models.

resultsFifteen ART programmes in 12 countries in Africa, South America and Asia were included. Chest X-ray, sputum microscopy and culture were available free of charge in respectively 13 (86.7%), 14 (93.3%) and eight (53.3%) programmes. Eight sites (53.3%) used directly observed treatment and five (33.3%) routinely administered isoniazid preventive treatment (IPT). A total of 19 413 patients aged ≥ 16 years contributed 13,227 person-years of follow-up; 1081 new TB events were diagnosed. Risk factors included CD4 cell count (>350 cells/μl vs. <25 cells/μl, adjusted IRR 0.46, 95%CI 0.33-0.64, P < 0.0001), sex (women vs. men, adjusted IRR 0.77, 95%CI 0.68-0.88, P = 0.0001) and use of IPT (IRR 0.24, 95%CI 0.19-0.31, P < 0.0001).

conclusionsDiagnostic capacity and practices vary widely across ART programmes. IPT prevented TB, but was used in few programmes. More efforts are needed to reduce the burden of TB in HIV co-infected patients in lower income countries.

Indexed as

AdolescentAdultAIDS-Related Opportunistic InfectionsAnti-HIV AgentsAntitubercular AgentsCoinfectionDeveloping CountriesFemaleFollow-Up StudiesHIV InfectionsHumansIsoniazidMaleMiddle AgedNational Health ProgramsPoisson DistributionAnti-HIV AgentsAntitubercular AgentsIsoniazid

Identifiers

PMID21756512
PMCPMC3140103
OpenAlexW2131036159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.